FDA warns company over ad that leaves out information on risk of overdose
Alkermes’s long-acting addiction medication, Vivitrol, leaves some former users more vulnerable to opioid overdoses. The company’s ad should warn them, the FDA says.
View original article
Contributor: Lenny Bernstein
